Medicines With The Active Ingredient Pazopanib Atc L01Ex03

Deadline: 31 Oct 2027

Germany

Ref. No.: 22448826

EMD:Ref Document

Bid Value: Ref Document

512 Days Left

Medicines With The Active Ingredient Tocilizumab Atc L04Ac07 For Subcutaneous Use

Deadline: 31 Oct 2027

Germany

Ref. No.: 22443462

EMD:Ref Document

Bid Value: Ref Document

512 Days Left

Maintenance Upkeep Renovation And Creation Of Fun And Sports Areas

Deadline: 01 Sep 2026

France

Ref. No.: 22440303

EMD:Ref Document

Bid Value: Ref Document

87 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 22428014

EMD:Ref Document

Bid Value: Ref Document

208 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 22421323

EMD:Ref Document

Bid Value: Ref Document

208 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 22414458

EMD:Ref Document

Bid Value: Ref Document

208 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 22412421

EMD:Ref Document

Bid Value: Ref Document

208 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Filgrastim

Deadline: 10 Nov 2027

Germany

Ref. No.: 22409643

EMD:Ref Document

Bid Value: Ref Document

522 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 22409147

EMD:Ref Document

Bid Value: Ref Document

208 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Teriparatide

Deadline: 10 Nov 2027

Germany

Ref. No.: 22407734

EMD:Ref Document

Bid Value: Ref Document

522 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Lebrikizumab Atc D11Ah10 For The Period January 1St 2026 December 31St 2027

Deadline: 01 Nov 2027

Germany

Ref. No.: 22372068

EMD:Ref Document

Bid Value: Ref Document

513 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Pazopanib Atc L01Ex03 For The Period January 1St 2026 December 31St 2027 Plus Extension Option 1X12 Months

Deadline: 05 Nov 2028

Germany

Ref. No.: 22371991

EMD:Ref Document

Bid Value: Ref Document

883 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Dimethyl Fumarate Atc D05Bx02 For The Period January 1St 2026 December 31St 2027

Deadline: 01 Nov 2027

Germany

Ref. No.: 22371804

EMD:Ref Document

Bid Value: Ref Document

513 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Paliperidone Exclusively 3 Month Depot Atc N05Ax13 For The Period January 1St 2026 December 31St 2027

Deadline: 05 Nov 2027

Germany

Ref. No.: 22371630

EMD:Ref Document

Bid Value: Ref Document

517 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Tildrakizumab Atc L04Ac17 For The Period January 1St 2026 December 31St 2027

Deadline: 01 Nov 2027

Germany

Ref. No.: 22371611

EMD:Ref Document

Bid Value: Ref Document

513 Days Left

Discover Tenders by Access Gates Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Access Gates Sector

Filter Your Search

FREE Trial plan for all new users!